01 1SM BIOMED
01 1ERYTHROMYCIN BASE USP
01 1Malaysia
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-10-03
Pay. Date : 2017-09-28
DMF Number : 24956
Submission : 2011-05-17
Status : Active
Type : II
20
Sm Biomed Sdn Bhd, based in Malaysia, is a pharmaceutical company.
One of their notable products is ERYTHROMYCIN BASE USP, with a corresponding US DMF Number 24956.
Remarkably, this DMF maintains an Active status since its submission on May 17, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 03, 2017, and payment made on September 28, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
